Healthcare -
Biotechnology - NASDAQ - US
$ 1.9
-1.04 %
$ 398 M
Market Cap
-1.23
P/E
ALLO - OTHER ACCUMULATIVE COMPREHENSIVE INCOME LOSS
Other Accumulative Comprehensive Income Loss ALLO - Allogene Therapeutics, Inc.
-955 K
LAST VALUE
39.01%
2 YEAR CAGR
-32.74%
5 YEAR CAGR
0.00%
10 YEAR CAGR